Report Detail

Pharma & Healthcare Global Swine Reproductive and Respiratory Syndrome Vaccine Market Research Report 2021

  • RnM4286139
  • |
  • 15 February, 2021
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Swine Reproductive and Respiratory Syndrome Vaccine Market Overview

  • 1.1 Product Overview and Scope of Swine Reproductive and Respiratory Syndrome Vaccine
  • 1.2 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Type
    • 1.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Active Vaccine
    • 1.2.3 Inactivated Vaccines
  • 1.3 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Application
    • 1.3.1 Swine Reproductive and Respiratory Syndrome Vaccine Sales Comparison by Application: (2021-2027)
    • 1.3.2 Government Tender
    • 1.3.3 Market Sales
  • 1.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Estimates and Forecasts
    • 1.4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2016-2027
    • 1.4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales 2016-2027
    • 1.4.3 Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Swine Reproductive and Respiratory Syndrome Vaccine Market Competition by Manufacturers

  • 2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Sites, Area Served, Product Type
  • 2.5 Swine Reproductive and Respiratory Syndrome Vaccine Market Competitive Situation and Trends
    • 2.5.1 Swine Reproductive and Respiratory Syndrome Vaccine Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Swine Reproductive and Respiratory Syndrome Vaccine Players Market Share by Revenue
    • 2.5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Swine Reproductive and Respiratory Syndrome Vaccine Retrospective Market Scenario by Region

  • 3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
    • 3.3.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
    • 3.3.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
    • 3.4.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
    • 3.4.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region
    • 3.5.2 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
    • 3.6.1 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
    • 3.6.2 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
    • 3.7.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Swine Reproductive and Respiratory Syndrome Vaccine Historic Market Analysis by Type

  • 4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2016-2021)
  • 4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2016-2021)
  • 4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2016-2021)

5 Global Swine Reproductive and Respiratory Syndrome Vaccine Historic Market Analysis by Application

  • 5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2016-2021)
  • 5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2016-2021)
  • 5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 ASCENT CORPORATION
    • 6.1.1 ASCENT CORPORATION Corporation Information
    • 6.1.2 ASCENT CORPORATION Description and Business Overview
    • 6.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 ASCENT CORPORATION Product Portfolio
    • 6.1.5 ASCENT CORPORATION Recent Developments/Updates
  • 6.2 Boehringer-Ingelheim
    • 6.2.1 Boehringer-Ingelheim Corporation Information
    • 6.2.2 Boehringer-Ingelheim Description and Business Overview
    • 6.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Boehringer-Ingelheim Product Portfolio
    • 6.2.5 Boehringer-Ingelheim Recent Developments/Updates
  • 6.3 MSD Animal Health
    • 6.3.1 MSD Animal Health Corporation Information
    • 6.3.2 MSD Animal Health Description and Business Overview
    • 6.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 MSD Animal Health Product Portfolio
    • 6.3.5 MSD Animal Health Recent Developments/Updates
  • 6.4 SPAH
    • 6.4.1 SPAH Corporation Information
    • 6.4.2 SPAH Description and Business Overview
    • 6.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 SPAH Product Portfolio
    • 6.4.5 SPAH Recent Developments/Updates
  • 6.5 Ceva
    • 6.5.1 Ceva Corporation Information
    • 6.5.2 Ceva Description and Business Overview
    • 6.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Ceva Product Portfolio
    • 6.5.5 Ceva Recent Developments/Updates
  • 6.6 Chengdu TECH-BANK Biological Products Co,.Ltd
    • 6.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Corporation Information
    • 6.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Description and Business Overview
    • 6.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Product Portfolio
    • 6.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments/Updates
  • 6.7 ringpu
    • 6.6.1 ringpu Corporation Information
    • 6.6.2 ringpu Description and Business Overview
    • 6.6.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 ringpu Product Portfolio
    • 6.7.5 ringpu Recent Developments/Updates
  • 6.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
    • 6.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Corporation Information
    • 6.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Description and Business Overview
    • 6.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Product Portfolio
    • 6.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments/Updates
  • 6.9 DAHUANONG
    • 6.9.1 DAHUANONG Corporation Information
    • 6.9.2 DAHUANONG Description and Business Overview
    • 6.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 DAHUANONG Product Portfolio
    • 6.9.5 DAHUANONG Recent Developments/Updates
  • 6.10 CAVAC
    • 6.10.1 CAVAC Corporation Information
    • 6.10.2 CAVAC Description and Business Overview
    • 6.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 CAVAC Product Portfolio
    • 6.10.5 CAVAC Recent Developments/Updates
  • 6.11 Komipharm
    • 6.11.1 Komipharm Corporation Information
    • 6.11.2 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Description and Business Overview
    • 6.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Komipharm Product Portfolio
    • 6.11.5 Komipharm Recent Developments/Updates
  • 6.12 Agrovet
    • 6.12.1 Agrovet Corporation Information
    • 6.12.2 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Description and Business Overview
    • 6.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Agrovet Product Portfolio
    • 6.12.5 Agrovet Recent Developments/Updates
  • 6.13 Bioveta
    • 6.13.1 Bioveta Corporation Information
    • 6.13.2 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Description and Business Overview
    • 6.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Bioveta Product Portfolio
    • 6.13.5 Bioveta Recent Developments/Updates
  • 6.14 JINYU BIO-TECNOLOGY CO.,LTD
    • 6.14.1 JINYU BIO-TECNOLOGY CO.,LTD Corporation Information
    • 6.14.2 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Description and Business Overview
    • 6.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 JINYU BIO-TECNOLOGY CO.,LTD Product Portfolio
    • 6.14.5 JINYU BIO-TECNOLOGY CO.,LTD Recent Developments/Updates
  • 6.15 Phibro Animal Health
    • 6.15.1 Phibro Animal Health Corporation Information
    • 6.15.2 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Description and Business Overview
    • 6.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Phibro Animal Health Product Portfolio
    • 6.15.5 Phibro Animal Health Recent Developments/Updates
  • 6.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
    • 6.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Corporation Information
    • 6.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Description and Business Overview
    • 6.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Product Portfolio
    • 6.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments/Updates
  • 6.17 Zoetis
    • 6.17.1 Zoetis Corporation Information
    • 6.17.2 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Description and Business Overview
    • 6.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Zoetis Product Portfolio
    • 6.17.5 Zoetis Recent Developments/Updates
  • 6.18 WINSUN BIO
    • 6.18.1 WINSUN BIO Corporation Information
    • 6.18.2 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Description and Business Overview
    • 6.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 WINSUN BIO Product Portfolio
    • 6.18.5 WINSUN BIO Recent Developments/Updates
  • 6.19 PULIKE BIOLOGICAL ENGINERING,INC.
    • 6.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Corporation Information
    • 6.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Description and Business Overview
    • 6.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Product Portfolio
    • 6.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments/Updates

7 Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Cost Analysis

  • 7.1 Swine Reproductive and Respiratory Syndrome Vaccine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Swine Reproductive and Respiratory Syndrome Vaccine
  • 7.4 Swine Reproductive and Respiratory Syndrome Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors List
  • 8.3 Swine Reproductive and Respiratory Syndrome Vaccine Customers

9 Swine Reproductive and Respiratory Syndrome Vaccine Market Dynamics

  • 9.1 Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends
  • 9.2 Swine Reproductive and Respiratory Syndrome Vaccine Growth Drivers
  • 9.3 Swine Reproductive and Respiratory Syndrome Vaccine Market Challenges
  • 9.4 Swine Reproductive and Respiratory Syndrome Vaccine Market Restraints

10 Global Market Forecast

  • 10.1 Swine Reproductive and Respiratory Syndrome Vaccine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Swine Reproductive and Respiratory Syndrome Vaccine by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Swine Reproductive and Respiratory Syndrome Vaccine by Type (2022-2027)
  • 10.2 Swine Reproductive and Respiratory Syndrome Vaccine Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Swine Reproductive and Respiratory Syndrome Vaccine by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Swine Reproductive and Respiratory Syndrome Vaccine by Application (2022-2027)
  • 10.3 Swine Reproductive and Respiratory Syndrome Vaccine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Swine Reproductive and Respiratory Syndrome Vaccine by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Swine Reproductive and Respiratory Syndrome Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Active Vaccine
    Inactivated Vaccines
    The segment of active vaccine holds a comparatively larger share in global market, which accounts for about 90%.

    Segment by Application
    Government Tender
    Market Sales
    The vaccine is fully applicated in market sales.

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    ASCENT CORPORATION
    Boehringer-Ingelheim
    MSD Animal Health
    SPAH
    Ceva
    Chengdu TECH-BANK Biological Products Co,.Ltd
    ringpu
    QILU ANIMAL HEALTH PRODUCTS CO.,LTD
    DAHUANONG
    CAVAC
    Komipharm
    Agrovet
    Bioveta
    JINYU BIO-TECNOLOGY CO.,LTD
    Phibro Animal Health
    ANHUI TIANKANG(GROUP)SHRES O., LTD
    Zoetis
    WINSUN BIO
    PULIKE BIOLOGICAL ENGINERING,INC.


    Summary:
    Get latest Market Research Reports on Swine Reproductive and Respiratory Syndrome Vaccine. Industry analysis & Market Report on Swine Reproductive and Respiratory Syndrome Vaccine is a syndicated market report, published as Global Swine Reproductive and Respiratory Syndrome Vaccine Market Research Report 2021. It is complete Research Study and Industry Analysis of Swine Reproductive and Respiratory Syndrome Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,080.05
    3,120.08
    4,160.11
    2,409.08
    3,613.62
    4,818.16
    312,045.80
    468,068.70
    624,091.60
    211,312.85
    316,969.28
    422,625.70
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report